Ohcanbohtosat - Sanjeevani Arora

  • Čájehuvvo 1 - 8 / 8
Aiddostahte ozu
  1. 1
    POLD1: Central mediator of DNA replication and repair, and implication in cancer and other pathologies

    POLD1: Central mediator of DNA replication and repair, and implication in cancer and other pathologies Dahkki Émmanuelle Nicolas, Erica A. Golemis, Sanjeevani Arora

    Almmustuhtton 2016
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Downregulation of XPF–ERCC1 enhances cisplatin efficacy in cancer cells☆

    Downregulation of XPF–ERCC1 enhances cisplatin efficacy in cancer cells☆ Dahkki Sanjeevani Arora, Anbarasi Kothandapani, Kristin Tillison, Vivian Kalman‐Maltese, Steve M. Patrick

    Almmustuhtton 2010
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Factors Associated With Racial and Ethnic Disparities in Locally Advanced Rectal Cancer Outcomes

    Factors Associated With Racial and Ethnic Disparities in Locally Advanced Rectal Cancer Outcomes Dahkki Rebecca M. Shulman, Mengying Deng, Elizabeth A. Handorf, Joshua E. Meyer, Shannon M. Lynch, Sanjeevani Arora

    Almmustuhtton 2024
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors

    Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors Dahkki Sanjeevani Arora, R. A. Velichinskii, Randy W. Lesh, Usman Ali, Michal Kubiak, Pranshu Bansal, Hossein Borghaei, Martin J. Edelman, Yanis Boumber

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Metabolic and proteomic signatures differentiate inflammatory phenotypes from cancer and predict treatment response in patient sera

    Metabolic and proteomic signatures differentiate inflammatory phenotypes from cancer and predict treatment response in patient sera Dahkki Gabriel Cutshaw, Elena V. Demidova, Philip Czyzewicz, Elizabeth Quam, Nicole Lorang, AL Warith AL Siyabi, Surinder K. Batra, Sanjeevani Arora, Rizia Bardhan

    Almmustuhtton 2025
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cells

    Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cells Dahkki Sanjeevani Arora, Joshua R. Heyza, Hao Zhang, Vivian Kalman‐Maltese, Kristin Tillison, Ashley M. Floyd, Elaine M. Chalfin, Gerold Bepler, Steve M. Patrick

    Almmustuhtton 2016
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer Cells

    Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer Cells Dahkki Joshua R. Heyza, Sanjeevani Arora, Hao Zhang, Kayla L. Conner, Wen Lei, Ashley M. Floyd, Rahul Deshmukh, Jeffrey Sarver, Christopher Trabbic, Paul Erhardt, Tak Hang Chan, Q. Ping Dou, Steve M. Patrick

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients

    Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients Dahkki Ilya G. Serebriiskii, Caitlin Connelly, Garrett M. Frampton, Justin Y. Newberg, Matthew Cooke, V. A. Miller, Siraj M. Ali, Jeffrey S. Ross, Elizabeth A. Handorf, Sanjeevani Arora, Christopher H. Lieu, Erica A. Golemis, Joshua E. Meyer

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: